Peritoneal metastases from colorectal cancer: patient selection for cytoreductive surgery and hyperthermic intraperitoneal chemotherapy.

No abstract is available for this paper.

• Publication year

  2013

• Venue

  European Journal of Surgical Oncology

• Publication date

  2013-09-01

• Fields of study

  Medicine

• Identifiers
  DOI 10.1016/j.ejso.2013.06.001PMID 23810280
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Should Patients With Peritoneal Carcinomatosis of Colorectal Origin With Synchronous Liver Metastases Be Treated With a Curative Intent? A Case-Control Study

  2013cited by this paper
• Summary of current therapeutic options for peritoneal metastases from colorectal cancer

  2013cited by this paper
• Hyperthermic Intraperitoneal Chemotherapy in Patients with Peritoneal Carcinomatosis: Role of Heat Shock Proteins and Dissecting Effects of Hyperthermia

  2013cited by this paper
• Is There a Possibility of a Cure in Patients With Colorectal Peritoneal Carcinomatosis Amenable to Complete Cytoreductive Surgery and Intraperitoneal Chemotherapy?

  2013cited by this paper
• Addition of Biological Therapies to Palliative Chemotherapy Prolongs Survival in Patients With Peritoneal Carcinomatosis of Colorectal Origin

  2013cited by this paper
• Value of laparoscopy before cytoreductive surgery and hyperthermic intraperitoneal chemotherapy for peritoneal carcinomatosis

  2013cited by this paper
• Cytoreductive surgery plus hyperthermic perioperative chemotherapy to treat peritoneal metastases from colorectal cancer: standard of care or an experimental approach?

  2012cited by this paper
• Treatment of colorectal peritoneal carcinomatosis with systemic chemotherapy: a pooled analysis of north central cancer treatment group phase III trials N9741 and N9841.

  2012cited by this paper
• Patient Selection for Cytoreductive Surgery in Colorectal Peritoneal Carcinomatosis Using Serum Tumor Markers: An Observational Cohort Study

  2012cited by this paper
• A new standard of care for the management of peritoneal surface malignancy.

  2011cited by this paper
• Mild elevation of body temperature reduces tumor interstitial fluid pressure and hypoxia and enhances efficacy of radiotherapy in murine tumor models.

  2011cited by this paper
• Curative treatment of colorectal peritoneal carcinomatosis: current status and future trends.

  2010cited by this paper
• Intraoperative hyperthermic intraperitoneal chemotherapy after cytoreductive surgery for peritoneal carcinomatosis in an experimental model

  2010cited by this paper
• Peritoneal colorectal carcinomatosis treated with surgery and perioperative intraperitoneal chemotherapy: retrospective analysis of 523 patients from a multicentric French study.

  2010cited by this paper
• Evaluation of Best Supportive Care and Systemic Chemotherapy as Treatment Stratified according to the retrospective Peritoneal Surface Disease Severity Score (PSDSS) for Peritoneal Carcinomatosis of Colorectal Origin

  2010cited by this paper
• A Systematic Review and Meta-Analysis of Cytoreductive Surgery with Perioperative Intraperitoneal Chemotherapy for Peritoneal Carcinomatosis of Colorectal Origin

  2009cited by this paper
• Strokes among childhood brain tumor survivors.

  2009cited by this paper
• Indications and patient selection for cytoreductive surgery and perioperative intraperitoneal chemotherapy

  2009cited by this paper
• 18F-FDG-PET/CT to Select Patients with Peritoneal Carcinomatosis for Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy

  2009cited by this paper
• Evaluation of Preoperative Computed Tomography in Estimating Peritoneal Cancer Index in Colorectal Peritoneal Carcinomatosis

  2009cited by this paper
• Complete cytoreductive surgery plus intraperitoneal chemohyperthermia with oxaliplatin for peritoneal carcinomatosis of colorectal origin.

  2009cited by this paper
• Evaluation of a peritoneal surface disease severity score in patients with colon cancer with peritoneal carcinomatosis

  2009cited by this paper
• 8-Year Follow-up of Randomized Trial: Cytoreduction and Hyperthermic Intraperitoneal Chemotherapy Versus Systemic Chemotherapy in Patients with Peritoneal Carcinomatosis of Colorectal Cancer

  2008cited by this paper
• Consensus statement on the loco regional treatment of colorectal cancer with peritoneal dissemination

  2008cited by this paper
• MRI evaluation of bulky tumor masses in the mesentery and bladder involvement in peritoneal carcinomatosis.

  2006cited by this paper
• Systematic review on the efficacy of cytoreductive surgery combined with perioperative intraperitoneal chemotherapy for peritoneal carcinomatosis from colorectal carcinoma.

  2006cited by this paper
• Treatment of synchronous peritoneal carcinomatosis and liver metastases from colorectal cancer.

  2006cited by this paper
• Peritoneal Carcinomatosis of Colorectal Origin: Incidence and Current Treatment Strategies

  2006cited by this paper
• Predicting the survival of patients with peritoneal carcinomatosis of colorectal origin treated by aggressive cytoreduction and hyperthermic intraperitoneal chemotherapy

  2004cited by this paper
• Value of 18F-FDG PET in the detection of peritoneal carcinomatosis

  2004cited by this paper
• Peritoneal carcinomatosis from colorectal or appendiceal origin: Correlation of preoperative CT with intraoperative findings and evaluation of interobserver agreement

  2004cited by this paper
• A theoretical model for intraperitoneal delivery of cisplatin and the effect of hyperthermia on drug penetration distance.

  2004cited by this paper
• Randomized trial of cytoreduction and hyperthermic intraperitoneal chemotherapy versus systemic chemotherapy and palliative surgery in patients with peritoneal carcinomatosis of colorectal cancer.

  2003cited by this paper
• Pseudomyxoma peritonei syndrome.

  1996cited by this paper
• Peritoneal carcinomatosis: natural history and rational therapeutic interventions using intraperitoneal chemotherapy.

  1996cited by this paper
• Clinical research methodologies in diagnosis and staging of patients with peritoneal carcinomatosis.

  1996cited by this paper
• Pseudomyxoma peritonei. A cancer whose biology is characterized by a redistribution phenomenon.

  1994cited by this paper
• Biological and Clinical Aspects of Hyperthermia in Cancer Therapy

  1988cited by this paper
• Hyperthermia in cancer therapy: the biological basis and unresolved questions.

  1985cited by this paper
• Clinical delivery system for intraperitoneal hyperthermic chemotherapy.

  1980cited by this paper

• Role of MDCT for selection of peritoneal carcinomatosis patients as candidates for cytoreductive surgery and hyperthermic intraperitoneal chemotherapy: Concordance between radiological and surgical scores using the Peritoneal Cancer Index.

  2025cites this paper
• CYTOTOXICITY TEST OF N-HEXANE, ETHYL ACETATE, AND WATER FRACTIONS FROM THE ETHANOL EXTRACT OF SENDUDUK LEAVES (Melastoma malabathricum L.) ON MCF-7 CELLS USING THE MTT ASSAY METHOD

  2024cites this paper
• Papel de la tomografía computarizada multidetector como herramienta de selección para cirugía de citorreducción y cirugía de citorreducción y quimioterapia intraperitoneal hipertérmica en la carcinomatosis peritoneal: concordancia entre el Índice de Carcinomatosis Peritoneal radiológico y quirúrgico

  2024cites this paper
• Cytoreductive surgery and hyperthermic intraperitoneal chemotherapy for colorectal peritoneal metastases: A pragmatic comparison of oncological outcomes in synchronous versus metachronous disease.

  2024cites this paper
• Botrytis cinerea: acetylcholinesterase inhibition, cytotoxicity, antimicrobial, larvicidal activity and metabolite isolated from fungal extract

  2024cites this paper
• Hyperthermic Intraperitoneal Chemotherapy with Mitomycin C versus Oxaliplatin after Cytoreductive Surgery for the Treatment of Peritoneal Metastases of Colorectal Cancer Origin.

  2022cites this paper
• Half of Postoperative Deaths After Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy Could be Preventable

  2021cites this paper
• Low Preoperative Serum Albumin Levels Are Associated With Impaired Outcome After Cytoreductive Surgery and Perioperative Intraperitoneal Chemotherapy for Peritoneal Surface Malignancies

  2020influential citation
• Centralization and Oncologic Training Reduce Postoperative Morbidity and Failure-to-rescue Rates After Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy for Peritoneal Surface Malignancies: Study on a 10-year National French Practice.

  2020cites this paper
• Identification and clinical validation of metastasis-associated biomarkers based on large-scale samples in colon-adenocarcinoma.

  2020cites this paper
• A real-world, population-based study of the outcomes of patients with metastatic colorectal cancer to the peritoneum treated with or without cytoreductive surgery

  2020cites this paper
• CMAR_A_270830 10587..10602

  2020cites this paper
• Conventional peritoneal cytology lacks the prognostic significance of detecting local or peritoneal recurrence in colorectal cancer: An Egyptian experience

  2020cites this paper
• Factors Prognostic for Peritoneal Metastases from Colorectal Cancer Treated with Surgery

  2020cites this paper
• Different Features of Tumor-Associated NK Cells in Patients With Low-Grade or High-Grade Peritoneal Carcinomatosis

  2019cites this paper
• Not all abdominal masses after colorectal cancer surgery are malignant: intra‐abdominal fibromatosis masquerading as recurrence

  2019cites this paper
• Hyperthermic Intraperitoneal Chemotherapy (HIPEC) and Cytoreductive Surgery (CRS) for Colorectal Cancer: Potential for Individualized Care, Review of Current Treatment Trends, Recent Advancements, and a Look into the Future

  2019cites this paper
• Outcome of Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy in Colorectal Cancer.

  2019cites this paper
• Can [18F]F-FDG PET/CT be used to assess the pre-operative extent of peritoneal carcinomatosis in patients with colorectal cancer?

  2019cites this paper
• Sites of Recurrence After Complete Cytoreduction and Hyperthermic Intraperitoneal Chemotherapy for Patients with Peritoneal Carcinomatosis from Colorectal and Appendiceal Adenocarcinoma: A Tertiary Center Experience

  2018cites this paper
• Cold Atmospheric Plasma (CAP) Combined with Chemo-Radiation and Cytoreductive Surgery: The First Clinical Experience for Stage IV Metastatic Colon Cancer

  2018cites this paper
• Preoperative CT-based predictive factors for resectability and medium-term overall survival in patients with peritoneal carcinomatosis from colorectal cancer.

  2018cites this paper
• Peritoneal Malignancies and Colorectal Peritoneal Metastases

  2017cites this paper
• Cytoreductive surgery and hyperthermic intraperitenoal chemotherapy (HIPEC) for colorectal and appendiceal carcinomas with peritoneal carcinomatosis.

  2017cites this paper
• A Perioperative Clinical Pathway Can Dramatically Reduce Failure-to-rescue Rates After Cytoreductive Surgery for Peritoneal Carcinomatosis: A Retrospective Study of 666 Consecutive Cytoreductions

  2017cites this paper
• Title : Management of Colorectal cancer in Nigeria in 2016

  2017cites this paper
• Abordagem Terapêutica da Carcinomatose Peritoneal em doentes com Carcinoma Colorretal

  2017cites this paper
• Systemic Treatment for Advanced Colorectal cancer : Bridging the gap between clinical studies and daily practice

  2017cites this paper
• Combination Treatment of Citral Potentiates the Efficacy of Hyperthermic Intraperitoneal Chemoperfusion with Pirarubicin for Colorectal Cancer.

  2017cites this paper
• Intraperitoneal-Free Cancer Cells Represent a Major Prognostic Factor in Colorectal Peritoneal Carcinomatosis

  2016influential citation
• Rak jelita czy rak jajnika? Niejednoznaczne rozpoznanie i niestandardowe leczenie z dobrym efektem. Studium przypadku

  2016cites this paper
• Nanoparticle tumor localization, disruption of autophagosomal trafficking, and prolonged drug delivery improve survival in peritoneal mesothelioma.

  2016cites this paper
• Surgery for Colorectal Cancer - Trends, Developments, and Future Perspectives

  2016cites this paper
• Unresectability during open surgical exploration in planned cytoreductive surgery and hyperthermic intraperitoneal chemotherapy*

  2016cites this paper
• Outcome of Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy on Patients with Diaphragmatic Involvement

  2015cites this paper
• Extreme cytoreductive surgery and hyperthermic intraperitoneal chemotherapy: Outcomes from a single tertiary center.

  2015cites this paper
• Nanovehicles as a novel target strategy for hyperthermic intraperitoneal chemotherapy: a multidisciplinary study of peritoneal carcinomatosis

  2015cites this paper
• Metastatic Colon and Rectal Cancer: Role of Multidisciplinary Team-Based Management

  2015cites this paper
• UvA-DARE ( Digital Academic Repository ) HIPEC treatment of peritoneal carcinomatosis in colorectal and gastric cancer

  2015cites this paper
• Poor outcome after cytoreductive surgery and HIPEC for colorectal peritoneal carcinomatosis with signet ring cell histology

  2015cites this paper
• Guidelines on the use of cytoreductive surgery and hyperthermic intraperitoneal chemotherapy in patients with peritoneal surface malignancy arising from colorectal or appendiceal neoplasms.

  2015cites this paper
• Trends in cytoreductive surgery and hyperthermic intraperitoneal chemotherapy for the treatment of synchronous peritoneal carcinomatosis of colorectal origin in the Netherlands.

  2015cites this paper
• Trends in cytoreductive surgery and hyperthermic intraperitoneal chemotherapy for the treatment of synchronous peritoneal carcinomatosis of colorectal origin in the Netherlands

  2015cites this paper
• The Role of Systemic Chemotherapy

  2015cites this paper
• Modern management of peritoneal carcinomatosis of colorectal origin - Is hyperthermic intraoperative peritoneal chemotherapy the treatment of first choice?

  2014cites this paper
• Outcomes with cytoreductive surgery and HIPEC for peritoneal metastasis

  2014cites this paper
• Peritoneal metastases of colorectal origin treated by cytoreduction and HIPEC: An overview.

  2014cites this paper
• Cytoreductive surgery in combination with hyperthermic intraperitoneal chemotherapy improves survival in patients with colorectal peritoneal metastases compared with systemic chemotherapy alone

  2014cites this paper
• Quality of life after cytoreductive surgery and intraoperative hyperthermic intraperitoneal chemotherapy for peritoneal surface malignancies: a systematic review.

  2014cites this paper
• Successful surgical approach for a patient with encapsulating peritoneal sclerosis after hyperthermic intraperitoneal chemotherapy: a case report and literature review

  2014cites this paper
• Hyperthermic intraperitoneal chemotherapy using a combination of mitomycin C,5-fluorouracil, and oxaliplatin in patients at high risk of colorectal peritoneal metastasis: A Phase I clinical study.

  2014cites this paper